The present invention is directed to novel imidazolidin-2-one derivativeshaving a structure according to Formula I, wherein a, b, R, R,R, and R are as defined above, pharmaceutical compositionscontaining them and their use in the treatment of disorders and conditions modulatedby the androgen receptor.